|

Oncaspar Clinical Trials

1 actively recruiting trial across 1 location

Also known as: NSC #624239), PEGASPARGASE

Pipeline

Phase 2: 1

Top Sponsors

  • Dana-Farber Cancer Institute1

Indications

  • Philadelphia Chromosome-Negative Lymphoblastic Leukemia1
  • Acute Lymphoblastic Leukemia (ALL)1
  • Leukemia1
  • Acute Lymphoblastic Leukemia1
  • Cancer1

Boston, Massachusetts1 trial

ALL Backbone in AYAs

Dana Farber Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.